Features of adipokine-mediated myocardial injury in patients with ST-segment elevation myocardial infarction
The aim of the study was to determine the features of adipokine-mediated myocardial injury in patients with ST-elevation myocardial infarction and excess body weight/obesity by assessing the relationship between leptin levels and metabolic disturbances with the severity of atherothrombosis and the severity of the course of acute coronary syndrome according to laboratory and instrumental data. A single-centre prospective cohort study was conducted, which included 120 patients with ST-segment elevation myocardial infarction, who were divided into three groups according to the body mass index: group 1 – excess body weight (25.0-29.9 kg/m², n = 42); group 2 – obesity (≥ 30 kg/m², n = 34); group 3 – normal body mass index (18.5-24.9 kg/m², n = 44). In the obesity group, the highest concentrations of leptin (57.27 ± 4.1 ng/mL) and troponin I (4.09 ± 4.33 ng/mL) were found, which significantly exceeded the indicators of the other groups (ANOVA p < 0.001). A strong positive relationship was established between the body mass index and leptin (r = 0.87; p < 0.001) and between leptin and troponin I (r = 0.46; p = 0.008), which indicated the functioning of a single adipokine-apoptotic axis in the context of myocardial injury. Instrumental methods confirmed a more severe nature of myocardial damage in obesity: lower left ventricular ejection fraction (46.3 ± 6.2%), higher left ventricular mass index (131 ± 22 g/m²), increased wall thickness, the greatest elevation of the ST segment (4.88 ± 2.10 mm; ANOVA p = 0.013), higher frequency of three-vessel lesion (28.6%), and maximal values according to the SYNTAX scale (24.5 ± 8.9 points; p < 0.001). Multiple regression analysis confirmed that the body mass index (β = 0.42; p < 0.001), SYNTAX (β = 0.36; p = 0.004), and reduced ejection fraction (β=–0.33; p= 0.008) are independent predictors of increased levels of troponin I
obesity; excess body weight; leptin; acute coronary syndrome; coronarography; ejection fraction; body mass index
https://doi.org/10.63341/bmbr/4.2025.68- Labinska OYe. Features of the course of acute myocardial infarction in patients with excess body weight and obesity [PhD dissertation]. Lviv: Danylo Halytsky Lviv National Medical University of the Ministry of Health of Ukraine; 2022.
- Zhebel VM, Starzhynska OL. New possibilities of using an ischemic cascade blocker in the treatment of acute myocardial infarction. Emerg Med. 2022;18(1):35–41. DOI: 10.22141/2224-0586.18.1.2022.1456
- Ismaiel A, Oliveira-Grilo G, Leucuta DC, Al Srouji N, Ismaiel M, Popa SL. Leptin unveiled: A potential biomarker for acute coronary syndrome with implications for tailored therapy in patients with type 2 diabetes – systematic review and meta-analysis. Int J Mol Sci. 2025;26(9):3925. DOI: 10.3390/ijms26093925
- Du B, Fu Q, Yang Y, Li R, Yang X, Yang Q, et al. Different types of cell death and their interactions in myocardial ischemia-reperfusion injury. Cell Death Discov. 2025;11:87. DOI: 10.1038/s41420-025-02372-5
- Liu SH, Lin YZ, Han S, Jin YZ. The obesity paradox in ST-segment elevation myocardial infarction patients after PCI: A meta-analysis. Ann Noninvasive Electrocardiol. 2023;28(2):e13022. DOI: 10.1111/anec.13022
- Ndrepepa G, Cassese S, Xhepa E, Joner M, Sager HB, Kufner S, et al. Coronary no-reflow and adverse events in patients with ST-segment elevation myocardial infarction undergoing primary PCI. Clin Res Cardiol. 2024;113:1006–16. DOI: 10.1007/s00392-023-02340-y
- Vilariño-García T, Polonio-González ML, Pérez-Pérez A, Ribalta J, Arrieta F, Aguilar M, et al. Role of leptin in obesity, cardiovascular disease, and COVID-19: Mechanisms and clinical implications. Int J Mol Sci. 2024;25(4):2338. DOI: 10.3390/ijms25042338
- Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–6. DOI: 10.1093/eurheartj/ehad191
- Liu L, Shi Z, Ji X, Zhang W, Luan J, Zahr T, et al. Adipokines, adiposity, and atherosclerosis. Cell Mol Life Sci. 2022;79(5):272. DOI: 10.1007/s00018-022-04286-2
- Skrypnik D, Skrypnik K, Suliburska J, Bogdański P. Cardiac rehabilitation may influence leptin and VEGF-A concentrations in patients after acute coronary syndrome: A randomized study. Sci Rep. 2022;12:11825. DOI: 10.1038/s41598-022-16053-1
- Sun X, Xin C, Yao J, Wang H. Relationship between leptin and heart failure: A systematic review and meta-analysis. Glob Heart. 2025;20(1):44. DOI: 10.5334/gh.1434
- Wang J, Liu S, Sun L, Kong Z, Chai J, Wen J, et al. Association of attenuated leptin signaling pathways with cardiac dysfunction under chronic hypoxia. Sci Rep. 2024;14:10206. DOI: 10.1038/s41598-024-59559-6
- Skalsky K, Shiyovich A, Steinmetz T, Kornowski R. Chronic renal failure and cardiovascular disease: A comprehensive appraisal. J Clin Med. 2022;11(5):1335. DOI: 10.3390/jcm11051335
- Order of the Ministry of Health of Ukraine No. 1936. Unified Clinical Protocol of Emergency, Primary, Secondary (Specialized), and Tertiary (Highly Specialized) Medical Care and Cardio-Rehabilitation “Acute Coronary Syndrome with ST-Segment Elevation” [Internet]. 2021 September 14 [cited 2025 February 13]. Available from: https://zakon.rada.gov.ua/rada/show/v1936282-21#n11
- The World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects
[Internet]. [cited 2025 October 13]. Available from: https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/ - Centers for Disease Control and Prevention. Adult BMI Categories [Internet]. 2024 March 19 [cited 2025 February 13]. Available from:
https://www.cdc.gov/bmi/adult-calculator/bmi-categories.html - Rao SS, Agasthi P. Thrombolysis in myocardial infarction risk score. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
- SYNTAX score calculator [Internet]. [cited 2025 February 13]. Available from: https://syntaxscore.org/
- Demirci D, Ersan Demirci D, Chi G. Association between obesity grade and the age of the first acute coronary syndrome: Prospective observational study. Int J Cardiol. 2022;351:93–9. DOI: 10.1016/j.ijcard.2021.11.080
- Fischer AJ, Feld J, Makowski L, Engelbertz C, Kühnemund L, Günster C, et al. ST-elevation myocardial infarction as a first event: Sex- and age-related mortality. Dtsch Arztebl Int. 2022;119:245–92. DOI: 10.3238/arztebl.m2022.0161
- Schmucker J, Kerniss H, Hanses U, Rühle S, Marín LAM, Osteresch R, et al. Severe obesity in patients with ST-elevation myocardial infarctions: Association with age, temporal trends, and clinical outcomes. Eur J Prev Cardiol. 2025:zwaf411. DOI: 10.1093/eurjpc/zwaf411
- Yastremska IO. Endothelial dysfunction and its management in patients with acute myocardial infarction combined with metabolic syndrome. Int J Med Med Res. 2020;6(2):37–43. DOI: 10.11603/ijmmr.2413-6077.2020.2.12012
- Puchałowicz K, Kłoda K, Dziedziejko V, Rać M, Wojtarowicz A, Chlubek D, et al. Association of adiponectin, leptin and resistin plasma concentrations with echocardiographic parameters in patients with coronary artery disease. Diagnostics. 2021;11(10):1774. DOI: 10.3390/diagnostics11101774
- Labinska O, Halkevych M, Kysil O, Bigun I. Features of coronary circulation in patients with acute myocardial infarction and obesity. Pract Physician. 2022;4:29–34.
- Samak K, Khalil M, El gendy E, Badr S. Serum leptin and SYNTAX score in acute coronary syndrome: Insights from a prospective observational study for risk stratification. BMS Cardiovas Dis. 2025:1–14. DOI: 10.21203/rs.3.rs-7511548/v1
- Mohamed A. Predicting mortality and no-reflow in STEMI patients using epicardial adipose tissue. Clin Cardiol. 2021;44(10):1371–6. DOI: 10.1002/clc.23692